Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,796.00
Bid: 6,795.00
Ask: 6,798.00
Change: -84.00 (-1.22%)
Spread: 3.00 (0.04%)
Open: 6,886.00
High: 6,919.00
Low: 6,792.00
Yest. Close: 6,880.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LONDON MARKET MIDDAY: Micro Focus, AstraZeneca Help Extend FTSE Rally

LONDON (Alliance News) - The FTSE 100 was posting its fourth consecutive session of gains on Thursday at midday as an overall improvement in market mood due to hopes for US-China trade talks got a

14 Feb 19 12:13

EXTRA: Cancer Drug Tagrisso Set To Be AstraZeneca's 2019 Best Seller

LONDON (Alliance News) - AstraZeneca PLC on Thursday posted particularly strong annual sales growth from its Oncology segment, with lung cancer drug Tagrisso set to become its biggest seller in in

14 Feb 19 11:25

WINNERS & LOSERS SUMMARY: ConvaTec Slumps On "Disappointing" Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Micro up

14 Feb 19 11:17

LONDON MARKET OPEN: Micro Focus, AstraZeneca Keep FTSE In Rally Mode

LONDON (Alliance News) - The FTSE 100 was sustaining its recent winning streak in early trade on Thursday, boosted by well-received annual results from Micro Focus International a

14 Feb 19 08:36

TOP NEWS: AstraZeneca Profit Falls, Guides To Earnings Growth In 2019

LONDON (Alliance News) - AstraZeneca PLC on Thursday posted a drop in annual profit after getting a boost from its Lynparza cancer drug collaboration the year before, though guided to earnings for

14 Feb 19 07:46

LONDON MARKET PRE-OPEN: Lower Call; Restaurant Group CEO To Depart

LONDON (Alliance News) - London share prices are set to pull back slightly on Thursday following three consecutive sessions of gains which had been driven by hopes of a trade detente between the a

14 Feb 19 07:46

AstraZeneca beats forecasts as new drug sales soar

(Sharecast News) - AstraZeneca reported a strong fourth quarter, beating market expectations for revenues and earnings, with the drugs colossus guiding to another strong year ahead.

14 Feb 19 07:45

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 8 February SSETrading Statement ShaftesburyTrading 11 MiningFull 12

7 Feb 19 16:07

FDA grants AstraZeneca's Fasenra orphan drug designation

(Sharecast News) - AstraZeneca said on Wednesday that the US Food and Drug Administration has granted orphan drug designation (ODD) to Fasenra for the treatment of hypereosinophilic syndrome (HES), a group of rare and potentially fatal disorders that can cause progressive damage to any organ in the body.

6 Feb 19 09:04

TOP NEWS: AstraZeneca's Fasenra Gets US FDA Orphan Drug Designation

LONDON (Alliance News) - AstraZeneca PLC on Wednesday said the US Food & Drug Administration has granted Orphan Drug Designation to Fasenra for the treatment of hypereosinophilic is first drug

6 Feb 19 07:57

LONDON MARKET PRE-OPEN: Barratt Profit Up; Interserve Gets Debt Deal

LONDON (Alliance News) - Stock prices in London on Wednesday are set to pull back from Tuesday's rally, while the pound remained below the USD1.30 mark after disappointing UK data released in

6 Feb 19 07:46

AstraZeneca oral diabetes treatment gets European marketing approval

(Sharecast News) - AstraZeneca said on Friday that the European Medicines Agency (EMA) has recommended marketing authorisation for its Forxiga treatment for use as an oral adjunct treatment to insulin in adults with type-1 diabetes.

1 Feb 19 15:02

Friday broker round-up

(Sharecast News) - Fresnillo: UBS upgrades to buy with a target price of 1,100p.

25 Jan 19 13:21

BROKER RATINGS SUMMARY: Citigroup And Goldman Downgrade Property Firms

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and late Thursday:----------FTSE 100----------GOLDMAN RAISES TO - TO

25 Jan 19 09:47

Monday broker round-up

(Sharecast News) - Next: Credit Suisse downgrades to underperform with a target price of 4,800p.

14 Jan 19 13:44

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.